Literature DB >> 8871838

In vitro effects of methotrexate on polyamine levels in lymphocytes from rheumatoid arthritis patients.

G Nesher1, T G Osborn, T L Moore.   

Abstract

OBJECTIVE: Several studies have documented increased levels of polyamines in rheumatoid arthritis (RA). We have suggested that one of the mechanisms of action of methotrexate (MTX) involves the inhibition of polyamine synthesis in lymphocytes. In this study, we sought to establish the inhibitory effect of MTX on polyamine synthesis and its specificity.
METHODS: Polyamine levels were determined in stimulated RA lymphocytes incubated in vitro with MTX and compared to levels in lymphocytes incubated with hydrocortisone, D-penicillamine, or medium alone. Lymphocyte polyamine levels were correlated with IgM-rheumatoid factor (RF) synthesis.
RESULTS: Incubation with MTX resulted in concentration-dependent decreased intracellular levels of spermidine and spermine, while putrescine levels were not affected. Addition of folinic acid or S-adenosyl-methionine (SAM) prevented this MTX-induced inhibition. Incubation with D-penicillamine or hydrocortisone had no significant effect on polyamine levels. There was a positive correlation between intracellular polyamine levels and the inhibition of IgM-RF synthesis by MTX.
CONCLUSION: These data suggest that MTX inhibits the synthesis of spermidine and spermine in stimulated RA lymphocytes through inhibition of the SAM-dependent pathway. This inhibition may be related to the immune-modulating properties of MTX.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871838

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  11 in total

1.  Going with the flow: methotrexate, adenosine, and blood flow.

Authors:  B N Cronstein
Journal:  Ann Rheum Dis       Date:  2006-04       Impact factor: 19.103

Review 2.  Methotrexate and its mechanisms of action in inflammatory arthritis.

Authors:  Bruce N Cronstein; Thomas M Aune
Journal:  Nat Rev Rheumatol       Date:  2020-02-17       Impact factor: 20.543

3.  The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis.

Authors:  Hee-Jin Park; Min-Chan Park; Yong-Beom Park; Soo-Kon Lee; Sang-Won Lee
Journal:  Rheumatol Int       Date:  2013-12-22       Impact factor: 2.631

Review 4.  Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers.

Authors:  Philip M Brown; Arthur G Pratt; John D Isaacs
Journal:  Nat Rev Rheumatol       Date:  2016-10-27       Impact factor: 20.543

5.  Adenosine in inflammatory joint diseases.

Authors:  E S L Chan; P Fernandez; B N Cronstein
Journal:  Purinergic Signal       Date:  2007-01-03       Impact factor: 3.765

Review 6.  Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers.

Authors:  Przemysław Koźmiński; Paweł Krzysztof Halik; Raphael Chesori; Ewa Gniazdowska
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

7.  Immunoregulatory Interplay Between Arginine and Tryptophan Metabolism in Health and Disease.

Authors:  Giada Mondanelli; Alberta Iacono; Massimo Allegrucci; Paolo Puccetti; Ursula Grohmann
Journal:  Front Immunol       Date:  2019-07-09       Impact factor: 7.561

8.  Prevention of multiple system atrophy using human bone marrow-derived mesenchymal stem cells by reducing polyamine and cholesterol-induced neural damages.

Authors:  Kyung-Ran Park; Chul Ju Hwang; Hyung-Mun Yun; In Jun Yeo; Dong-Young Choi; Pil-Hoon Park; Hyung Sook Kim; Jung Tae Lee; Young Suk Jung; Sang-Bae Han; Jin Tae Hong
Journal:  Stem Cell Res Ther       Date:  2020-03-04       Impact factor: 6.832

Review 9.  The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions.

Authors:  Shahin Shams; Joseph M Martinez; John R D Dawson; Juan Flores; Marina Gabriel; Gustavo Garcia; Amanda Guevara; Kaitlin Murray; Noah Pacifici; Maxemiliano V Vargas; Taylor Voelker; Johannes W Hell; Judith F Ashouri
Journal:  Front Pharmacol       Date:  2021-05-28       Impact factor: 5.810

Review 10.  Molecular action of methotrexate in inflammatory diseases.

Authors:  Edwin S L Chan; Bruce N Cronstein
Journal:  Arthritis Res       Date:  2002-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.